SCHEMBL6978482

SCHEMBL6978482

CNC(=O)c1ccc2c(c1)C(=C(Nc1cccc(CN(C)C)c1)c1ccccc1)C(=O)N2

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ROCK2 O75116 3/20 0.39
PTGES O14684 1/20 0.39
BCHE P06276 2/20 0.38
PAK4 O96013 6/20 0.37
KDM1A O60341 1/20 0.37
RCOR1 Q9UKL0 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
NPSR1 Q6W5P4 1/20 0.36
KIT P10721 1/20 0.36
PDGFRA P16234 1/20 0.36
KDR P35968 1/20 0.36
AURKA O14965 1/20 0.36
RPS6KB1 P23443 1/20 0.36
ALDH1A1 P00352 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KCNK3 O14649 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6978475 1.00 MEN1 (0.40) MEN1KMT2AROCK2PTGESBCHE
SCHEMBL3148082 0.93 PTGES (0.41) MEN1KMT2AROCK2PTGESBCHE
SCHEMBL3148074 0.93 PTGES (0.41) MEN1KMT2AROCK2PTGESBCHE
SCHEMBL6982535 0.91 ROCK2 (0.43) ROCK2PAK4CYP3A4CYP2C9
SCHEMBL6982529 0.91 ROCK2 (0.43) ROCK2PAK4CYP3A4CYP2C9
SCHEMBL6971265 0.90 JAK3 (0.41) MEN1KMT2AROCK2PTGESBCHE
SCHEMBL6971260 0.90 JAK3 (0.41) MEN1KMT2AROCK2PTGESBCHE
SCHEMBL7227041 0.90 KDM1A (0.39) MEN1KMT2AROCK2BCHEKDM1A
SCHEMBL7227045 0.90 KDM1A (0.39) MEN1KMT2AROCK2BCHEKDM1A
SCHEMBL6986773 0.90 LMNA (0.42) ROCK2BCHEPAK4CYP3A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1071665-B1 SUBSTITUTED INDOLINONES HAVING AN INHIBITING EFFECT ON KINASES AND CYCLINE/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA (DE) 2003-10-01 EP disclosed
US-6169106-B1 ANTITUMOUR AGENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-01-02 US disclosed